NCT07039110 Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis Status RECRUITING Phase N/A
NCT07032597 A Study to Assess Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Restoration and/or Creation of Mid-Face Volume in Adult Participants Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT07024797 Study to Assess the Adverse Events, Tolerability, and How Oral Doses of ABBV-932 Moves Through the Body in Healthy Adult Chinese Participants Status COMPLETED Phase PHASE1
NCT07024784 A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies Status RECRUITING Phase PHASE2
NCT07024706 Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab Status NOT_YET_RECRUITING Phase PHASE2
NCT07023302 A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata Status RECRUITING Phase PHASE3
NCT07023289 A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease Status RECRUITING Phase PHASE2
NCT07018752 A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas Status RECRUITING Phase PHASE1/PHASE2
NCT07007091 A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administrations With a Pre-Filled Syringe or an On-Body Injector in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT07007065 Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) Status RECRUITING Phase PHASE3
NCT07007052 Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients Status NOT_YET_RECRUITING Phase PHASE2
NCT07005102 A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE2/PHASE3
NCT06977724 A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD) Status RECRUITING Phase PHASE1
NCT06972446 A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis Status RECRUITING Phase PHASE2
NCT06972056 Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study Status RECRUITING Phase PHASE4
NCT06965374 Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease Status RECRUITING Phase N/A
NCT06958705 Venetoclax as Consolidation in CLL Patients Treated With BTK Inhibitor Monotherapy Status RECRUITING Phase PHASE2
NCT06953960 A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM) Status RECRUITING Phase PHASE1/PHASE2
NCT06953934 A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants Status NOT_YET_RECRUITING Phase PHASE1
NCT06946524 A Study to Assess the Bioavailability of Risankizumab Following Subcutaneous Administration With Prefilled Pen Relative to a Prefilled Syringe in Healthy Adult Participants Status COMPLETED Phase PHASE1